MetLife Investment Management’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.9K | Buy |
21,928
+4,852
| +28% | +$21.9K | ﹤0.01% | 2542 |
|
|
2025
Q1 | $75.6K | Sell |
17,076
-5,065
| -23% | -$22.4K | ﹤0.01% | 2628 |
|
|
2024
Q4 | $173K | Hold |
22,141
| – | – | ﹤0.01% | 2366 |
|
|
2024
Q3 | $291K | Hold |
22,141
| – | – | ﹤0.01% | 2081 |
|
|
2024
Q2 | $267K | Buy |
22,141
+2,055
| +10% | +$24.8K | ﹤0.01% | 2064 |
|
|
2024
Q1 | $327K | Hold |
20,086
| – | – | ﹤0.01% | 1918 |
|
|
2023
Q4 | $137K | Hold |
20,086
| – | – | ﹤0.01% | 2446 |
|
|
2023
Q3 | $109K | Hold |
20,086
| – | – | ﹤0.01% | 2531 |
|
|
2023
Q2 | $136K | Hold |
20,086
| – | – | ﹤0.01% | 2502 |
|
|
2023
Q1 | $101K | Buy |
20,086
+6,895
| +52% | +$34.5K | ﹤0.01% | 2550 |
|
|
2022
Q4 | $64.4K | Sell |
13,191
-7,492
| -36% | -$36.6K | ﹤0.01% | 2723 |
|
|
2022
Q3 | $298K | Hold |
20,683
| – | – | ﹤0.01% | 2031 |
|
|
2022
Q2 | $313K | Hold |
20,683
| – | – | ﹤0.01% | 1991 |
|
|
2022
Q1 | $246K | Buy |
20,683
+7,268
| +54% | +$86.3K | ﹤0.01% | 2230 |
|
|
2021
Q4 | $217K | Hold |
13,415
| – | – | ﹤0.01% | 2001 |
|
|
2021
Q3 | $383K | Hold |
13,415
| – | – | ﹤0.01% | 1683 |
|
|
2021
Q2 | $453K | Hold |
13,415
| – | – | ﹤0.01% | 1626 |
|
|
2021
Q1 | $406K | Hold |
13,415
| – | – | ﹤0.01% | 1647 |
|
|
2020
Q4 | $664K | Hold |
13,415
| – | – | 0.01% | 1329 |
|
|
2020
Q3 | $515K | Hold |
13,415
| – | – | 0.01% | 1353 |
|
|
2020
Q2 | $580K | Buy |
13,415
+3,344
| +33% | +$144K | 0.01% | 1299 |
|
|
2020
Q1 | $263K | Hold |
10,071
| – | – | ﹤0.01% | 1547 |
|
|
2019
Q4 | $315K | Hold |
10,071
| – | – | ﹤0.01% | 1718 |
|
|
2019
Q3 | $262K | Hold |
10,071
| – | – | ﹤0.01% | 1786 |
|
|
2019
Q2 | $230K | Buy |
+10,071
| New | +$230K | ﹤0.01% | 1944 |
|